|
Status |
Public on Mar 15, 2017 |
Title |
Integrative epigenomic analysis in MLL-AF9 acute myeloid leukemia (AML) and B-acute lymphoblastic leukemia (B-ALL) |
Organism |
Homo sapiens |
Experiment type |
Methylation profiling by high throughput sequencing Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
27780967 |
Submission date |
Aug 04, 2015 |
Last update date |
May 15, 2019 |
Contact name |
Magalie Celton |
E-mail(s) |
magalie.celton@umontreal.ca
|
Organization name |
IRIC
|
Lab |
High-throughput sequencing
|
Street address |
2950, Chemin de Polytechnique
|
City |
Montreal |
State/province |
Quebec |
ZIP/Postal code |
H3T1J4 |
Country |
Canada |
|
|
Platforms (2) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
GPL15520 |
Illumina MiSeq (Homo sapiens) |
|
Samples (55)
|
|
This SuperSeries is composed of the following SubSeries:
|
GSE70755 |
Integrative epigenomic analysis in MLL-AF9 acute myeloid leukemia (AML) and B-acute lymphoblastic leukemia (B-ALL) |
GSE71686 |
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets [RNA-Seq_AML] |
GSE71689 |
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets [RNA-Seq_normal] |
GSE71800 |
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) |
GSE71840 |
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) |
GSE72041 |
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq shRNA) |
GSE72061 |
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (Leukemia Cell Bank) |
|
Relations |
BioProject |
PRJNA291821 |